Amedeo Smart

Free Medical Literature Service



Alzheimer's Disease

  Free Subscription

Articles published in
    May 2024
  1. NOLAN T
    A potential new treatment for Alzheimer's disease ... and other research.
    BMJ. 2024;385:q1125.
    >> Share

    February 2024
    Sixty seconds on . . . Viagra and Alzheimer's disease.
    BMJ. 2024;384:q370.
    >> Share

  3. DYER O
    Aduhelm: Biogen abandons Alzheimer's drug after controversial approval left it unfunded by Medicare.
    BMJ. 2024;384:q281.
    >> Share

    October 2023
  4. DALY TP
    Informing consent to antibodies in Alzheimer's disease.
    BMJ. 2023;383:p2350.
    >> Share

    August 2023
  5. HOWARD R, Kales HC
    New treatments for Alzheimer's disease.
    BMJ. 2023;382:1852.
    >> Share

    July 2023
    Donanemab leads to modest slowing of Alzheimer's progression, study finds.
    BMJ. 2023;382:p1659.
    >> Share

    Alzheimer's disease: Lecanemab gets full FDA approval and black box safety warning.
    BMJ. 2023;382:p1580.
    >> Share

    June 2023
  8. POURHADI N, Morch LS, Holm EA, Torp-Pedersen C, et al
    Menopausal hormone therapy and dementia: nationwide, nested case-control study.
    BMJ. 2023;381:e072770.
    >> Share

    March 2023
    Lecanemab: US Veterans Health Administration will cover cost of new Alzheimer's drug.
    BMJ. 2023;380:p628.
    >> Share

    January 2023
  10. MAHASE E
    Alzheimer's disease: FDA approves lecanemab amid cost and safety concerns.
    BMJ. 2023;380:p73.
    >> Share

  11. TANNE JH
    Aduhelm: Approval of Alzheimer's drug was highly unorthodox, finds report.
    BMJ. 2023;380:p6.
    >> Share

    December 2022
  12. WALSH S, Merrick R, Richard E, Nurock S, et al
    Lecanemab for Alzheimer's disease.
    BMJ. 2022;379:o3010.
    >> Share

    August 2022
  13. DYER O
    Alzheimer's: Alleged image manipulation in seminal paper casts doubt on leading hypothesis of disease.
    BMJ. 2022;378:o2041.
    >> Share

    April 2022
  14. DHANA K, Franco OH, Ritz EM, Ford CN, et al
    Healthy lifestyle and life expectancy with and without Alzheimer's dementia: population based cohort study.
    BMJ. 2022;377:e068390.
    >> Share

    March 2022
  15. DYER O
    Long delayed publication of data on Alzheimer's drug Aduhelm leaves questions unanswered.
    BMJ. 2022;376:o808.
    >> Share

    January 2022
  16. LYTHGOE MP, Jenei K, Prasad V
    Regulatory decisions diverge over aducanumab for Alzheimer's disease.
    BMJ. 2022;376:e069780.
    >> Share

    December 2021
  17. MAHASE E
    Aducanumab: European agency rejects Alzheimer's drug over efficacy and safety concerns.
    BMJ. 2021;375:n3127.
    >> Share

    November 2021
  18. HAMILTON F, West C
    Predatory marriage: Doctors can help to spot and prevent this exploitation.
    BMJ. 2021;375:n2906.
    >> Share

    September 2021
  19. VINOGRADOVA Y, Dening T, Hippisley-Cox J, Taylor L, et al
    Use of menopausal hormone therapy and risk of dementia: nested case-control studies using QResearch and CPRD databases.
    BMJ. 2021;374:n2182.
    >> Share

    August 2021
  20. ILIFFE S, Manthorpe J
    Aducanumab, amyloid, and culture wars.
    BMJ. 2021;374:n2038.
    >> Share

    July 2021
  21. DYER O
    FDA calls for investigation into industry influence during Alzheimer's drug approval.
    BMJ. 2021;374:n1778.
    >> Share

  22. WALSH S, Merrick R, Milne R, Brayne C, et al
    Aducanumab for Alzheimer's disease?
    BMJ. 2021;374:n1682.
    >> Share

    June 2021
  23. MAHASE E
    Three FDA advisory panel members resign over approval of Alzheimer's drug.
    BMJ. 2021;373:n1503.
    >> Share

  24. MAHASE E
    FDA approves controversial Alzheimer's drug despite uncertainty over effectiveness.
    BMJ. 2021;373:n1462.
    >> Share

    February 2021
  25. ACKLEY SF, Zimmerman SC, Brenowitz WD, Tchetgen Tchetgen EJ, et al
    Effect of reductions in amyloid levels on cognitive change in randomized trials: instrumental variable meta-analysis.
    BMJ. 2021;372:n156.
    >> Share

    October 2020
  26. SHI J, Sabbagh MN, Vellas B
    Alzheimer's disease beyond amyloid: strategies for future therapeutic interventions.
    BMJ. 2020;371:m3684.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016